Like Upd3, IL-6 activates JAK/STAT signaling in host organs and leads to weight loss (Belizário et al., 2016; Bonetto et al., 2012; Ma et al., 2017; Miller et al., 2017), indicating a conserved role for IL-6/Upd3 in cancer cachexia. This evidence concerns the gene IL6 and cancer.